Abstract
Recently, Lei et al., (2018) published an article in Cancer Medicine claiming a survival benefit of sphingosine 1-phosphate (S1P) and sphingosine 1-phosphate receptor 1 (S1P1) expression in breast cancer patients. This controversial study opposes the prevailing view concerning the deleterious role of S1P in cancer. This is discussed in depth in the current opinion article.
| Original language | English |
|---|---|
| Pages (from-to) | 1-3 |
| Number of pages | 3 |
| Journal | Frontiers in Oncology |
| Volume | 8 |
| Issue number | 417 |
| DOIs | |
| Publication status | Published - 27 Sept 2018 |
Keywords
- sphingosine 1-phosphate
- Sphingosine 1-phosphate receptor 1
- breast cancer
- migration
- growth